HOME › DRUGS › TREMELIMUMAB-ACTL
ACTIVE SUBSTANCE / INN

TREMELIMUMAB-ACTL

Brand name(s): IMJUDO
FDA LISTED
PRESCRIPTION
BLA761289
ACTIVE SUBSTANCE
Tremelimumab-Actl
REGULATORS
FDA
SPONSORS / MAH
ASTRAZENECA AB
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
IMJUDOBLA761289ASTRAZENECA ABPrescription

FULL INTELLIGENCE ON TREMELIMUMAB-ACTL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →